Global Prostate Laser Surgery Market Size, Share and Trends Analysis Report – Industry Overview and Forecast to 2033

Prostate Laser Surgery Market Size

• The global prostate laser surgery market size was valued at USD 2.62 billion in 2025 and is expected to reach USD 4.63 billion by 2033, at a CAGR of 7.34% during the forecast period
• The market growth is largely fueled by the increasing prevalence of benign prostatic hyperplasia (BPH) and prostate-related disorders, coupled with advancements in minimally invasive surgical technologies and laser-based therapeutic techniques
• Furthermore, rising patient preference for procedures that offer reduced recovery time, minimal complications, and enhanced precision is driving the adoption of prostate laser surgeries in hospitals and specialized clinics. These converging factors are accelerating the uptake of advanced laser surgical solutions, thereby significantly boosting the industry's growth

Prostate Laser Surgery Market Analysis

• Prostate laser surgeries, offering minimally invasive laser-based treatment for benign prostatic hyperplasia (BPH) and other prostate-related disorders, are increasingly preferred in modern urological care due to their precision, reduced bleeding, shorter hospital stays, and faster patient recovery
• The escalating demand for prostate laser surgeries is primarily fueled by the rising prevalence of BPH and prostate conditions, growing patient awareness about minimally invasive procedures, and a preference for treatments with fewer complications compared to traditional surgical methods
• North America dominated the prostate laser surgery market with the largest revenue share of 38.5% in 2025, characterized by advanced healthcare infrastructure, high patient awareness, and the presence of leading medical device manufacturers, with the U.S. witnessing substantial growth in laser-assisted procedures in hospitals and specialized urology centers driven by technological innovations and adoption of next-generation laser systems
• Asia-Pacific is expected to be the fastest growing region in the prostate laser surgery market during the forecast period due to increasing geriatric population, rising healthcare expenditure, and growing access to advanced medical technologies
• Holmium Laser Ablation of the Prostate segment dominated the prostate laser surgery market with a market share of 45.3% in 2025, driven by its proven efficacy in tissue ablation, lower complication rates, and widespread clinical adoption in urology practices

Report Scope and Prostate Laser Surgery Market Segmentation     

Prostate Laser Surgery Market Trends

Advancements in Minimally Invasive Laser Technologies

• A significant and accelerating trend in the global prostate laser surgery market is the continuous innovation in laser systems, such as Holmium and GreenLight lasers, offering enhanced precision, reduced bleeding, and shorter recovery periods
  • For instance, the latest Holmium laser systems incorporate high-power settings and improved tissue ablation efficiency, enabling surgeons to perform procedures faster while minimizing complications
• Integration with imaging technologies, including real-time ultrasound and endoscopic guidance, allows for more accurate targeting of prostate tissue and personalized treatment plans for patients
• The adoption of robotic-assisted laser surgery systems is facilitating greater procedural accuracy and ergonomic efficiency for urologists, while also reducing surgeon fatigue during complex interventions
• This trend towards more precise, patient-friendly, and technology-driven laser procedures is fundamentally reshaping clinical expectations for prostate surgery outcomes
• The demand for advanced laser systems with shorter hospital stays, reduced post-operative complications, and enhanced patient comfort is growing rapidly across both hospital and outpatient care settings
• Growing collaborations between laser device manufacturers and hospitals are driving innovation in user-friendly interfaces and integrated software solutions for improved surgical workflow
• Increasing use of telemedicine and remote monitoring technologies in post-operative care is supporting faster patient recovery and enhancing the overall adoption of laser-based prostate treatments

Prostate Laser Surgery Market Dynamics

Driver

Rising Prevalence of BPH and Patient Preference for Minimally Invasive Procedures

• The increasing incidence of benign prostatic hyperplasia (BPH) and prostate-related disorders, combined with patient preference for minimally invasive treatment, is a major driver for the rising adoption of prostate laser surgeries
  • For instance, in March 2025, Boston Scientific introduced an upgraded GreenLight XPS laser system designed to improve procedural efficiency and patient recovery in BPH treatment, reflecting industry innovation driving market growth
• As awareness of complications associated with traditional transurethral resection of the prostate (TURP) grows, patients and physicians are increasingly opting for laser-assisted procedures with reduced bleeding and catheterization times
• Hospitals and specialized urology centers are investing in next-generation laser systems to meet patient demand for safer, faster, and more effective treatments
• Furthermore, the growing geriatric population with rising healthcare awareness and disposable income is accelerating adoption of advanced laser surgical interventions
• Increasing partnerships between laser device manufacturers and healthcare providers are promoting wider availability and training programs for advanced laser procedure
• Government initiatives and reimbursement policies supporting minimally invasive surgeries are further incentivizing the adoption of prostate laser surgery

Restraint/Challenge

High Equipment Costs and Limited Skilled Workforce

• The relatively high cost of advanced prostate laser surgery systems and maintenance presents a significant challenge, particularly for smaller hospitals and clinics in developing regions
  • For instance, the upfront investment required for Holmium or GreenLight laser platforms can exceed that of traditional surgical equipment, discouraging adoption in cost-sensitive markets
• In addition, a limited number of trained urologists proficient in laser-assisted procedures restricts broader market penetration and procedural availability
• The steep learning curve associated with new laser systems and the need for specialized training programs further constrain market growth in emerging regions
• While ongoing efforts in training and financing solutions are improving accessibility, the high initial investment and workforce limitations continue to pose barriers to widespread adoption
• Addressing these challenges through cost-effective solutions, increased surgeon training initiatives, and financial support programs will be essential for sustained market expansion
• Regulatory approvals and compliance requirements for new laser devices can slow down market entry and adoption in certain regions
• Variability in insurance coverage and reimbursement for laser procedures compared to conventional surgeries can limit patient access and adoption, particularly in developing countries

Prostate Laser Surgery Market Scope

The market is segmented on the basis of type and end user.

• By Type

On the basis of type, the prostate laser surgery market is segmented into Photoselective Vaporization of the Prostate (PVP), Holmium Laser Ablation of the Prostate (HoLAP), and Holmium Laser Enucleation of the Prostate (HoLEP). Holmium Laser Ablation of the Prostate (HoLAP) segment dominated the prostate laser surgery market with a market share of 45.3% in 2025, driven by its proven precision in tissue ablation, minimal bleeding risk, and suitability for patients with moderate to severe BPH. Hospitals and specialized urology centers widely adopt HoLAP due to its minimally invasive nature, shorter catheterization period, and faster recovery compared to traditional surgeries. Technological advancements in HoLAP devices, such as high-power laser systems and improved fiber delivery, have enhanced surgical efficiency and patient outcomes. Patient preference for reduced complications and improved post-operative comfort further reinforces its market dominance. Clinical acceptance and established procedural protocols make HoLAP a widely preferred choice among urologists globally.

The PVP segment is anticipated to witness the fastest growth rate of 18.9% from 2026 to 2033, fueled by its shorter catheterization period, reduced bleeding risk, and suitability for outpatient procedures. PVP is increasingly preferred for patients on anticoagulant therapy or with comorbidities that increase surgical risk. The adoption of high-powered GreenLight laser systems enables precise tissue vaporization, improving procedural outcomes and patient satisfaction. Rising awareness about minimally invasive procedures and rapid recovery is driving the adoption of PVP in both hospital and clinic settings. Manufacturers are focusing on developing advanced PVP laser platforms with enhanced energy efficiency and user-friendly interfaces, contributing to segment growth. Growing physician training programs and procedural standardization in emerging regions also support faster adoption of PVP technologies.

• By End User

On the basis of end user, the prostate laser surgery market is segmented into hospitals, specialized clinics, and others. The hospitals segment dominated the market with the largest revenue share of 52.8% in 2025, owing to the availability of advanced surgical infrastructure, experienced urologists, and high patient volumes. Hospitals are preferred for complex cases, large prostate sizes, and patients with comorbidities that require comprehensive perioperative care. The segment benefits from strong adoption of next-generation laser systems and integration with imaging technologies for precise interventions. In addition, hospitals are at the forefront of clinical trials and technological upgrades, ensuring early access to innovative laser platforms. The dominance of hospitals is further reinforced by insurance coverage and reimbursement policies that make laser procedures more accessible to patients.

The specialized clinics segment is expected to witness the fastest growth rate of 20.3% from 2026 to 2033, driven by the rising preference for outpatient and office-based laser procedures that offer convenience, reduced costs, and faster recovery. Clinics provide flexible scheduling, personalized care, and minimally invasive solutions, appealing to patients seeking shorter hospital stays. Increased awareness of laser treatment benefits and growing partnerships between clinics and device manufacturers are accelerating adoption. Clinics are also expanding their capabilities with portable laser systems and streamlined workflows to meet the growing demand for prostate laser surgeries. The proliferation of specialized urology centers in urban and semi-urban regions supports rapid segment growth, making clinics a key driver of market expansion.

Prostate Laser Surgery Market Regional Analysis

• North America dominated the prostate laser surgery market with the largest revenue share of 38.5% in 2025, characterized by advanced healthcare infrastructure, high patient awareness, and the presence of leading medical device manufacturers
• Patients and healthcare providers in the region highly value the precision, minimal invasiveness, and faster recovery offered by laser-assisted prostate surgeries compared to conventional procedures
• This widespread adoption is further supported by well-established hospitals and specialized urology centers, insurance coverage, and favorable reimbursement policies, establishing laser surgeries as a preferred treatment option for BPH and other prostate-related disorders

U.S. Prostate Laser Surgery Market Insight

The U.S. prostate laser surgery market captured the largest revenue share of 42% in 2025 within North America, fueled by the widespread adoption of minimally invasive procedures and advanced laser systems. Patients are increasingly prioritizing treatments that offer precision, reduced bleeding, and faster recovery compared to traditional TURP surgeries. The growing preference for outpatient and office-based procedures, combined with robust demand for Holmium and GreenLight laser technologies, further propels the market. Moreover, the presence of leading medical device manufacturers, high healthcare expenditure, and supportive reimbursement policies are significantly contributing to market expansion.

Europe Prostate Laser Surgery Market Insight

The Europe prostate laser surgery market is projected to expand at a substantial CAGR throughout the forecast period, primarily driven by rising incidence of BPH and increasing awareness of minimally invasive surgical options. The increase in urbanization, coupled with the demand for advanced healthcare services, is fostering the adoption of laser surgeries. European patients and healthcare providers are drawn to procedures that reduce hospital stays, lower complication rates, and enhance post-operative quality of life. The region is experiencing significant growth across hospitals, specialized urology clinics, and outpatient care centers, with laser surgeries being increasingly preferred for both new and complex cases.

U.K. Prostate Laser Surgery Market Insight

The U.K. prostate laser surgery market is anticipated to grow at a noteworthy CAGR during the forecast period, driven by rising awareness of prostate health and the preference for minimally invasive treatment options. In addition, the increasing prevalence of BPH and other prostate disorders is encouraging hospitals and clinics to adopt laser-based solutions. The UK’s well-established healthcare infrastructure, coupled with government-backed healthcare initiatives, is expected to continue stimulating market growth. Patient preference for reduced procedural risks, shorter recovery times, and better clinical outcomes is further supporting the adoption of laser-assisted prostate surgeries.

Germany Prostate Laser Surgery Market Insight

The Germany prostate laser surgery market is expected to expand at a considerable CAGR during the forecast period, fueled by advanced healthcare facilities and the availability of cutting-edge laser technologies. Germany’s focus on innovation and patient-centered care promotes the adoption of minimally invasive surgical procedures, particularly in urology. The integration of laser systems with imaging technologies for precise interventions is increasingly prevalent. Hospitals and specialized clinics are adopting prostate laser surgeries to meet patient demand for safer, efficient, and high-quality treatment options. In addition, growing awareness of post-operative benefits and enhanced recovery experiences is driving market growth.

Asia-Pacific Prostate Laser Surgery Market Insight

The Asia-Pacific prostate laser surgery market is poised to grow at the fastest CAGR of 22% during the forecast period of 2026 to 2033, driven by increasing geriatric population, rising healthcare expenditure, and growing awareness of minimally invasive treatments in countries such as China, Japan, and India. The region's growing inclination towards advanced urological procedures, supported by government healthcare initiatives and rising private hospital networks, is driving adoption. Furthermore, as APAC emerges as a hub for medical device manufacturing and distribution, the accessibility and affordability of laser systems are expanding to a wider patient base.

Japan Prostate Laser Surgery Market Insight

The Japan prostate laser surgery market is gaining momentum due to the country’s advanced healthcare system, high patient awareness, and increasing prevalence of BPH. The Japanese market places significant emphasis on precision, safety, and post-operative recovery, and the adoption of laser-assisted surgeries is driven by hospitals and specialized urology centers. Integration of laser systems with imaging technologies and minimally invasive surgical protocols is fueling growth. Moreover, Japan's aging population is expected to spur demand for safer, quicker, and more effective prostate treatments across both residential and clinical settings.

India Prostate Laser Surgery Market Insight

The India prostate laser surgery market accounted for the largest market revenue share in Asia Pacific in 2025, attributed to the country's growing geriatric population, rising awareness of prostate health, and improving healthcare infrastructure. India is witnessing an increasing number of hospitals and specialized clinics adopting minimally invasive laser procedures for BPH and other prostate disorders. The push towards advanced treatment options and availability of cost-effective laser systems are key factors propelling the market. In addition, government initiatives to expand access to quality healthcare, coupled with rising disposable incomes, are driving the adoption of prostate laser surgeries across urban and semi-urban regions.

Prostate Laser Surgery Market Share

The Prostate Laser Surgery industry is primarily led by well-established companies, including:

• Boston Scientific Corporation (U.S.)
• KARL STORZ SE & Co. KG (Germany)
• Richard Wolf GmbH (Germany)
• Cook (U.S.)
• Quanta System S.p.A. (Italy)
• biolitec AG (Germany)
• Convergent Laser Technologies (U.S.)
• Medtronic (Ireland)
• Dornier MedTech GmbH (Germany)
• Procept BioRobotics Corporation (U.S.)
• Urologix, LLC. (U.S.)
• Unique Medical Devices (India)
• JenaSurgical GmbH (Germany)
• CoreTherm Medical, Inc. (U.S.)
• Pnn Medical A/S (Denmark)
• Allengers Medical Systems Limited (India)
• CONMED Corporation (U.S.)
• Urotronic, Inc. (U.S.)
• SonaCare Medical, LLC (U.S.)
• Olympus Corporation (Japan)

What are the Recent Developments in Global Prostate Laser Surgery Market?

• In June 2025, Greenwich Hospital (USA) successfully performed its first HoLEP procedure, making advanced laser‑based prostate surgery accessible to patients in Fairfield and Westchester counties expanding access from large academic centers to community hospitals
• In May 2025, Sandwell and West Birmingham NHS Trust (UK) at the Midland Metropolitan University Hospital started offering HoLEP for enlarged prostate patients for the first time under their care signaling growing adoption of minimally invasive laser-based prostate surgery within public health systems and expanding access for patients
• In March 2025, Andromeda Surgical disclosed strategic partnerships with Richard Wolf (endoscopic imaging / surgical instrumentation) and Quanta System (laser‑technology provider) to accelerate global clinical development and deployment of their robotic HoLEP platform a step toward scaling minimally-invasive prostate surgery worldwide
• In December 2024, Andromeda Surgical announced the world’s first robotic‑assisted Holmium Laser Enucleation of the Prostate (HoLEP) procedure, marking a milestone in urological surgery as the first HoLEP ever done with robotic assistance via a tablet‑based interface, shifting HoLEP toward easier adoption and standardized performance globally
• In August 2024, Fortis Hospital & Kidney Institute, Kolkata (India) reported a successful HoLEP surgery in a 76‑year-old man with a very large prostate (≈ 290 g), demonstrating that advanced laser prostate surgery is feasible and effective even for very large prostate glands broadening the patient profiles for whom laser interventions can be successful

SKU-47834